AHR Form 4 reports disposition transactions

Willhite Gabriel M reported disposition transactions in a Form 4 filing for AHR.

Accepted by SEC EDGAR 02/11/2026 - 04:22 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Willhite Gabriel M reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 17,133 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 131,352 shares.

Insider Trade Summary

Exercise Price or Tax Liability: 17,133 shares

Exercise Price or Tax Liability 1 txn

Insider Willhite Gabriel M

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	17,133	$48.77	$836K

Holdings After Transaction: Common Stock — 131,352 shares (Direct)

Holdings Before and After: Common Stock, 148,485 to 131,352 shares (Direct)

Footnotes (2)

1. F1. Represents shares repurchased by the Issuer on February 9, 2026 to satisfy the Reporting Person's tax obligations associated with the vesting of shares of restricted common stock on February 9, 2026.
2. F2. Includes 1,059 shares acquired under the Issuer's Employee Stock Purchase Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AHR’s COO report in this Form 4?

American Healthcare REIT’s COO, Gabriel M. Willhite, reported a tax-withholding disposition. On February 9, 2026, the issuer repurchased 17,133 shares of common stock at $48.77 per share to satisfy his tax obligations from vesting restricted stock, rather than an open-market sale.

How many AHR shares were involved in Gabriel Willhite’s tax-withholding transaction?

The transaction involved 17,133 shares of American Healthcare REIT common stock. These shares were repurchased by the company on February 9, 2026 at $48.77 per share to cover tax obligations tied to the vesting of restricted stock, classified as a tax-withholding disposition.

Did AHR’s COO sell shares on the open market in this filing?

No, the filing shows a tax-withholding disposition, not an open-market sale. The issuer repurchased 17,133 shares on February 9, 2026 to satisfy Gabriel Willhite’s tax obligations from vesting restricted common stock, consistent with transaction code F on the Form 4.

How many American Healthcare REIT shares does the COO own after this transaction?

After the reported transaction, Gabriel Willhite beneficially owned 131,352 shares of American Healthcare REIT common stock directly. This figure includes 1,059 shares acquired under the company’s Employee Stock Purchase Plan, as disclosed in the Form 4 footnotes and ownership table.

What does transaction code F mean in the AHR COO’s Form 4?

Transaction code F indicates payment of a tax liability or exercise price using securities. In this case, 17,133 shares of American Healthcare REIT common stock were repurchased by the issuer to satisfy Gabriel Willhite’s tax obligations from vesting restricted shares, rather than being sold on the market.

What role does Gabriel M. Willhite hold at American Healthcare REIT (AHR)?

Gabriel M. Willhite is the Chief Operating Officer of American Healthcare REIT. The Form 4 identifies him as an officer, not a director or 10% owner, and reports his direct beneficial ownership in company common stock following the tax-withholding disposition on February 9, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Willhite Gabriel M

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE, STE 300

(Street)

IRVINE CA 92612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		F		17,133(1)	D	$48.77	131,352(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares repurchased by the Issuer on February 9, 2026 to satisfy the Reporting Person's tax obligations associated with the vesting of shares of restricted common stock on February 9, 2026.

2. Includes 1,059 shares acquired under the Issuer's Employee Stock Purchase Plan.

	/s/ GABRIEL M. WILLHITE	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.